Kerr Douglas

Head of R&D and CMO

Kerr Douglas has filed 9 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Oct 22, 2026.

On the most recent filing, Kerr Douglas is listed as Chief Medical Officer at Dyne Therapeutics, Inc. Inside the rolling window, Kerr Douglas reported no open-market purchases and 7 open-market sales totaling $233K in DYN. The largest disclosed transaction in the window is a sale of 3,745 DYN shares on Sep 4, 2026, worth $91K.

Companies traded

Other insiders at DYN

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$233K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
DYNSale$91KSep 8SEC ↗
DYNSale$24KSep 8SEC ↗
DYNSale$41KAug 17SEC ↗
DYNSale$16KJun 17SEC ↗
DYNSale$29KMay 14SEC ↗
DYNSale$13KMar 6SEC ↗
DYNSale$18KDec 5SEC ↗
Showing 1–7 of 7
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 5, 2025DYNSale$12K
Sep 4, 2025DYNSale$47K
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Kerr Douglas made?

Kerr Douglas has filed 9 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.

Which companies does Kerr Douglas trade?

Kerr Douglas has filed SEC Form 4 disclosures for 1 company, including DYN.

When was Kerr Douglas's most recent SEC Form 4 filing?

Kerr Douglas's most recent SEC Form 4 filing on Tracefour is dated Oct 22, 2026.

What is Kerr Douglas's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Kerr Douglas is listed as Head of R&D and CMO.

What is Kerr Douglas's total buy and sell value in the current window?

Inside the rolling retention window, Kerr Douglas bought $0 and sold $233K based on SEC Form 4 filings.

What was Kerr Douglas's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 3,745 DYN shares on 2026-09-04, worth $91K, per SEC Form 4 filings.